Belvedere Trading LLC Terns Pharmaceuticals, Inc. Transaction History

Belvedere Trading LLC

  • $74.4 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
SELL
$3.37 - $6.86 $6,429 - $13,088
-1,908 Reduced 6.85%
25,963 $168,000
Q3 2023

Oct 27, 2023
SELL
$4.7 - $8.55 $35,047 - $63,757
-7,457 Reduced 21.11%
27,871 $140,000
Q2 2023

Aug 08, 2023
BUY
$7.35 - $13.29 $259,660 - $469,509
35,328 New
35,328 $309,000

Others Institutions Holding TERN

# of Institutions
167
Shares Held
78.3M
Call Options Held
580K
Put Options Held
454K
View Full List

About Terns Pharmaceuticals, Inc.

TERN Quotes by TradingView
  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $214M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email